Dexcom has been cash flow positive for since 2014 and more recently moved into positive earnings territory. While revenue has grown very quickly, research and development expenses and selling, general ...

Time in range metrics were similar, if not better, among older vs younger adults with T1D using automated insulin delivery systems.

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

CBSE allows students with Type 1 diabetes to carry insulin pumps and glucometers, highlighting the need for paediatric ...

Babies with mothers who had maternal gestational diabetes are more likely to experience health benefits from breast milk ...

An advanced hybrid closed-loop insulin delivery system is safe to use for pregnant women with type 1 diabetes and may provide ...

driven by strong demand for Medtronic’s Continuous Glucose Monitoring (CGM) solutions. In addition, the MiniMed 780G system has also gained significant traction globally. However, the GLP-1 ...

The Food and Drug Administration on Tuesday classified Medtronic’s recall of its Pipeline Vantage embolization devices as the most serious type of recall. The recall removed Pipeline Vantage 027 ...

Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of incomplete wall apposition and braid deformation, which could lead to stroke ...

Medtronic has recalled embolization devices collectively linked to reports of 17 injuries and four deaths, the Food and Drug Administration said Tuesday. The recall has two elements: Medtronic is ...

Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a product recall involving the company’s Pipeline Vantage 027 ...